Literature DB >> 19086862

Adipose proteome analysis: focus on mediators of insulin resistance.

Xiaoli Chen1, Sonja Hess.   

Abstract

As is well known, adipose tissue is an important site for lipid metabolism and insulin-responsive glucose uptake. The recent discovery of the endocrine function of adipose tissue and the association of obesity with chronic low-grade inflammation in adipose tissue has reinforced the concept of the central role of adipose tissue in mediating obesity-linked insulin resistance and metabolic dysregulation. The study of adipose cells has provided new insights into the mechanism underlying insulin resistance as well as the therapeutic strategies for diabetes. Numerous efforts have been made in identifying key molecular regulators of insulin action and metabolism, including the utilization of advanced proteomics technology. Various proteomic approaches have been applied to identify the adipose secretome, protein-expression profiling and post-translational modifications in adipose cells in the pathological state. In this review, we summarize the recent advances in the proteomics of adipose tissue, and discuss the identified proteins that potentially play important roles in insulin resistance and diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19086862      PMCID: PMC2651673          DOI: 10.1586/14789450.5.6.827

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  103 in total

Review 1.  The lipocalin protein family: structure and function.

Authors:  D R Flower
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

2.  An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3.

Authors:  E Garay-Rojas; M Harper; S Hraba-Renevey; M Kress
Journal:  Gene       Date:  1996-05-08       Impact factor: 3.688

Review 3.  Generalized lipodystrophy, congenital and acquired (lipoatrophy).

Authors:  M Seip; O Trygstad
Journal:  Acta Paediatr Suppl       Date:  1996-06

Review 4.  Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.

Authors:  S K Fried; D A Bunkin; A S Greenberg
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

5.  Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils.

Authors:  L Kjeldsen; D F Bainton; H Sengeløv; N Borregaard
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

6.  Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha.

Authors:  J M Stephens; P H Pekala
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

7.  Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

Authors:  R Feinstein; H Kanety; M Z Papa; B Lunenfeld; A Karasik
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

8.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

Review 10.  Pathophysiology of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

View more
  8 in total

Review 1.  Obesidomics: contribution of adipose tissue secretome analysis to obesity research.

Authors:  Maria Pardo; Arturo Roca-Rivada; Luisa Maria Seoane; Felipe F Casanueva
Journal:  Endocrine       Date:  2012-03-21       Impact factor: 3.633

2.  Influence of secreted factors from human adipose tissue on glucose utilization and proinflammatory reaction.

Authors:  Karine Tréguer; Rodolphe Dusaulcy; Sandra Grès; Estelle Wanecq; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Physiol Biochem       Date:  2013-01-27       Impact factor: 4.158

3.  Characterization of the Human Adipocyte Proteome and Reproducibility of Protein Abundance by One-Dimensional Gel Electrophoresis and HPLC-ESI-MS/MS.

Authors:  Xitao Xie; Zhengping Yi; Benjamin Bowen; Cassandra Wolf; Charles R Flynn; Sandeep Sinha; Lawrence J Mandarino; Christian Meyer
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

4.  Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing.

Authors:  Juan R Peinado; Pedro M Quirós; Marina R Pulido; Guillermo Mariño; Maria L Martínez-Chantar; Rafael Vázquez-Martínez; José M P Freije; Carlos López-Otín; María M Malagón
Journal:  Mol Cell Proteomics       Date:  2011-08-09       Impact factor: 5.911

5.  iTRAQ-Based Quantitative Proteomic Comparison of 2D and 3D Adipocyte Cell Models Co-cultured with Macrophages Using Online 2D-nanoLC-ESI-MS/MS.

Authors:  Sun Young Lee; Sung Bum Park; Young Eun Kim; Hee Min Yoo; Jongki Hong; Kyoung-Jin Choi; Ki Young Kim; Dukjin Kang
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

6.  Proteomics in the characterization of adipose dysfunction in obesity.

Authors:  David Brockman; Xiaoli Chen
Journal:  Adipocyte       Date:  2012-01-01       Impact factor: 4.534

7.  Integrating post-genomic approaches as a strategy to advance our understanding of health and disease.

Authors:  Jing Tang; Chong Yew Tan; Matej Oresic; Antonio Vidal-Puig
Journal:  Genome Med       Date:  2009-03-30       Impact factor: 11.117

8.  Quantitative secretome and glycome of primary human adipocytes during insulin resistance.

Authors:  Jae-Min Lim; Edith E Wollaston-Hayden; Chin Fen Teo; Dorothy Hausman; Lance Wells
Journal:  Clin Proteomics       Date:  2014-05-12       Impact factor: 3.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.